CZ183999A3 - Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby - Google Patents

Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby Download PDF

Info

Publication number
CZ183999A3
CZ183999A3 CZ991839A CZ183999A CZ183999A3 CZ 183999 A3 CZ183999 A3 CZ 183999A3 CZ 991839 A CZ991839 A CZ 991839A CZ 183999 A CZ183999 A CZ 183999A CZ 183999 A3 CZ183999 A3 CZ 183999A3
Authority
CZ
Czechia
Prior art keywords
compound
compounds
dosage range
hydrogen
unsubstituted
Prior art date
Application number
CZ991839A
Other languages
Czech (cs)
English (en)
Inventor
Thomas Lee Cupps
Sophie Eva Bogdan
Raymond Todd Henry
Russell James Sheldon
William Lee Seibel
Jeffrey Joseph Ares
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of CZ183999A3 publication Critical patent/CZ183999A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ991839A 1996-11-25 1997-11-21 Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby CZ183999A3 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25

Publications (1)

Publication Number Publication Date
CZ183999A3 true CZ183999A3 (cs) 1999-11-17

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ991839A CZ183999A3 (cs) 1996-11-25 1997-11-21 Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby

Country Status (20)

Country Link
EP (1) EP0944620A1 (tr)
JP (1) JP2001506599A (tr)
KR (1) KR20000069104A (tr)
CN (1) CN1244864A (tr)
AR (1) AR010643A1 (tr)
AU (1) AU5433998A (tr)
BR (1) BR9713535A (tr)
CA (1) CA2272644A1 (tr)
CO (1) CO4910166A1 (tr)
CZ (1) CZ183999A3 (tr)
HU (1) HUP9904660A3 (tr)
ID (1) ID22676A (tr)
IL (1) IL130067A0 (tr)
NO (1) NO992502L (tr)
NZ (1) NZ335882A (tr)
PE (1) PE47099A1 (tr)
SK (1) SK69699A3 (tr)
TR (1) TR199901542T2 (tr)
WO (1) WO1998023609A1 (tr)
ZA (1) ZA9710576B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
WO2009084695A1 (ja) 2007-12-28 2009-07-09 Carna Biosciences Inc. ２－アミノキナゾリン誘導体
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists
ATE194771T1 (de) * 1993-12-17 2000-08-15 Procter & Gamble 6-(2-imidazolinylamino) chinoxalin-verbindungen als alpha-2-adrenorezeptoragonisten

Also Published As

Publication number Publication date
JP2001506599A (ja) 2001-05-22
AU5433998A (en) 1998-06-22
ID22676A (id) 1999-12-09
CA2272644A1 (en) 1998-06-04
WO1998023609A1 (en) 1998-06-04
BR9713535A (pt) 2000-03-21
TR199901542T2 (tr) 2000-01-21
SK69699A3 (en) 2000-06-12
HUP9904660A2 (hu) 2000-06-28
KR20000069104A (ko) 2000-11-25
NO992502L (no) 1999-07-26
NZ335882A (en) 2000-12-22
CO4910166A1 (es) 2000-04-24
ZA9710576B (en) 1998-09-16
EP0944620A1 (en) 1999-09-29
IL130067A0 (en) 2000-02-29
NO992502D0 (no) 1999-05-25
PE47099A1 (es) 1999-06-12
AR010643A1 (es) 2000-06-28
HUP9904660A3 (en) 2002-02-28
CN1244864A (zh) 2000-02-16

Similar Documents

Publication Publication Date Title
CZ184099A3 (cs) Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby
EP0944621B1 (en) 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
US5916900A (en) 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
CZ183999A3 (cs) Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby
CZ183799A3 (cs) Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby
US6172095B1 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
US6306877B1 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
CA2285610A1 (en) 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
MXPA99004843A (en) Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic